Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Hypertension (Atenolol - Hypertension)

Records returned : 50 (on 29 May 2025 at 11:34:56). Return to search results for ' Hypertension '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

Drug:

Indication :

Hypertension

Status :

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

10.

Drug:

Indication :

Hypertension

Status :

Green

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

2. Atenolol

Drug:

Atenolol

Indication :

Hypertension

Status :

Green

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Important

Preferred

Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

3. Amlodipine

Drug:

Amlodipine

Indication :

Hypertension

Status :

Green

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Preferred

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

4. Bisoprolol fumarate

Drug:

Bisoprolol fumarate

Indication :

Hypertension

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Preferred

Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

5. Candesartan cilexetil

Drug:

Candesartan cilexetil

Indication :

Hypertension

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Preferred

Preferred angiotensin II receptor blocker

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

6. Co-tenidone (Atenolol/chlortalidone)

Drug:

Co-tenidone (Atenolol/chlortalidone)

Indication :

Hypertension

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

7. Diltiazem hydrochloride

Drug:

Diltiazem hydrochloride

Indication :

Hypertension

Status :

Green

Formulations :

Modified release tablets

Restrictions / Comments:

Important

Prescribe by BRAND

Tildiem Retard (TWICE daily) are the lowest cost brand in Primary Care for patients requiring a tablet formulation.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

8. Diltiazem hydrochloride

Drug:

Diltiazem hydrochloride

Indication :

Hypertension

Status :

Green

Formulations :

Modified release capsules

Restrictions / Comments:

Important

Prescribe by BRAND

Angitil SR capsules (TWICE daily) or Zemtard XL or Slozem (ONCE daily) are the lowest cost brands for Primary Care.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

9. Doxazosin mesilate

Drug:

Doxazosin mesilate

Indication :

Hypertension

Status :

Green

Formulations :

Immediate release tablets

Restrictions / Comments:

Important

Step 4 of the hypertension pathway.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

47. Doxazosin mesilate

Drug:

Doxazosin mesilate

Indication :

Hypertension

Status :

Non Formulary

Formulations :

Modified release tablets

Restrictions / Comments:

Important

Step 4 of the hypertension pathway.

Use immediate release tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

11. Indapamide

Drug:

Indapamide

Indication :

Hypertension

Status :

Green

Formulations :

Modified release tablets
Tablets

Restrictions / Comments:

Important

Preferred

Preferred thiazide diuretic

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

12. Irbesartan

Drug:

Irbesartan

Indication :

Hypertension

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

13. Lercanidipine hydrochloride

Drug:

Lercanidipine hydrochloride

Indication :

Hypertension

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

14. Lisinopril

Drug:

Lisinopril

Indication :

Hypertension

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Use an ARB where possible. If an ACEi is required (patient with heart failure or post MI), ramipril is the preferred option.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

30. Lisinopril

Drug:

Lisinopril

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Oral solution

Restrictions / Comments:

Important

Use an ARB where possible. If an ACEi is required (patient with heart failure or post MI), ramipril is the preferred option.

Liquid is very expensive (>£200 for 150ml - Drug Tariff Sep 2024).

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

15. Losartan potassium

Drug:

Losartan potassium

Indication :

Hypertension

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Preferred

Preferred angiotensin II receptor blocker

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

16. Moxonidine

Drug:

Moxonidine

Indication :

Hypertension

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

ASPH restrict use to cardiology only.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

17. Nifedipine

Drug:

Nifedipine

Indication :

Hypertension

Status :

Green

Formulations :

Modified release tablets

Restrictions / Comments:

Important

Prescribe by BRAND

Tensipine MR (Twice daily) and Adipine XL (once daily) are the preferred tablet brands.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

18. Nifedipine

Drug:

Nifedipine

Indication :

Hypertension

Status :

Green

Formulations :

Modified release capsules

Restrictions / Comments:

Important

Prescribe by BRAND

Coracten SR (Twice daily) and Coracten XL (once daily) are the preferred capsule brands.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

19. Nifedipine

Drug:

Nifedipine

Indication :

Hypertension

Status :

Green

Formulations :

Capsules

Restrictions / Comments:

Important

Prescribe by BRAND

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

20. Olmesartan medoxomil

Drug:

Olmesartan medoxomil

Indication :

Hypertension

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

21. Quinapril hydrochloride

Drug:

Quinapril hydrochloride

Indication :

Hypertension

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

22. Ramipril

Drug:

Ramipril

Indication :

Hypertension

Status :

Green

Formulations :

Capsules

Restrictions / Comments:

Important

Preferred

Use an ARB where possible. If an ACEi is required (patient with heart failure or post MI), ramipril is the preferred option.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

23. Telmisartan

Drug:

Telmisartan

Indication :

Hypertension

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

24. Valsartan

Drug:

Valsartan

Indication :

Hypertension

Status :

Green

Formulations :

Capsules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

25. Bendroflumethiazide

Drug:

Bendroflumethiazide

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Indapamide is the preferred diuretic treatment option. No requirement to switch from bendroflumethiazide in stable patients.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

26. Captopril

Drug:

Captopril

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Not 1st line

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

27. Carvedilol

Drug:

Carvedilol

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

28. Enalapril maleate

Drug:

Enalapril maleate

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Preferred ACE inhibitor during breastfeeding (where an ACE inhibitor is appropriate)

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

29. Irbesartan / Hydrochlorothiazide

Drug:

Irbesartan / Hydrochlorothiazide

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Not Specified

Restrictions / Comments:

Important

MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

31. Lisinopril / Hydrochlorothiazide

Drug:

Lisinopril / Hydrochlorothiazide

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

32. Metoprolol tartrate

Drug:

Metoprolol tartrate

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

33. Nebivolol

Drug:

Nebivolol

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

34. Perindopril erbumine

Drug:

Perindopril erbumine

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

2mg, 4mg and 8mg tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

35. Prazosin hydrochloride

Drug:

Prazosin hydrochloride

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Only the 500mcg tablets are licensed in the UK. 2mg and 5mg tablets as special order or import only (much more expensive)

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

36. Propranolol hydrochloride

Drug:

Propranolol hydrochloride

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Modified release capsules
Oral solution
Tablets

Restrictions / Comments:

Important

Not a preferred beta blocker for hypertension. The cardio-selective betablockers, bisoprolol or atenolol are the preferred options

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

37. Spironolactone

Drug:

Spironolactone

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Step 4 of the hypertension pathway. Adjunct in resistant hypertension

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

38. Valsartan with hydrochlorothiazide

Drug:

Valsartan with hydrochlorothiazide

Indication :

Hypertension

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

39. Clonidine hydrochloride

Drug:

Clonidine hydrochloride

Indication :

Hypertension

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Reserved for severe / resistant hypertension.

Initiation and stabilisation by the specialist before transfer of prescribing to GP.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

40. Hydralazine hydrochloride

Drug:

Hydralazine hydrochloride

Indication :

Hypertension

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Prescribing in primary care on specialist recommendation only. Reserved for severe / resistant hypertension.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

41. Hydralazine hydrochloride

Drug:

Hydralazine hydrochloride

Indication :

Hypertension

Status :

Red

Formulations :

Intravenous infusion
Intravenous injection (IV)

Restrictions / Comments:

Important

Hypertensive emergency (including pregnancy) or hypertension with renal complications

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

42. Nicardipine hydrochloride

Drug:

Nicardipine hydrochloride

Indication :

Hypertension

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Important

Specialist only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

43. Aliskiren

Drug:

Aliskiren

Indication :

Hypertension

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Important

NHS England guidance DO NOT ROUTINELY PRESCRIBE

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

44. Azilsartan medoxomil

Drug:

Azilsartan medoxomil

Indication :

Hypertension

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

45. Celiprolol hydrochloride

Drug:

Celiprolol hydrochloride

Indication :

Hypertension

Status :

Non Formulary

Formulations :

Tablets

Restrictions / Comments:

Important

Not for initiation in new patients. Existing patients may remain on therapy.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

46. Chlortalidone

Drug:

Chlortalidone

Indication :

Hypertension

Status :

Non Formulary

Formulations :

Tablets

Restrictions / Comments:

Important

Not for initiation in new patients.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

48. Eprosartan

Drug:

Eprosartan

Indication :

Hypertension

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

49. Metolazone

Drug:

Metolazone

Indication :

Hypertension

Status :

Non Formulary

Formulations :

Tablets

Restrictions / Comments:

Important

The licensed (Xaqua) and unlicensed (Zaroxolyn) tablets have different bioavailabilities. These products are not interchangable=Prescribe by Brand

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

50. Perindopril arginine

Drug:

Perindopril arginine

Indication :

Hypertension

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Important

NHS England guidance DO NOT ROUTINELY PRESCRIBE

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1